Amylyx Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.7M | 121k | 13.91 |
| 2025-12-31 | $1.3M | 108k | 12.09 |
| 2025-09-30 | $1.4M | 100k | 13.60 |
| 2025-06-30 | $586k | 91k | 6.41 |
| 2025-03-31 | $205k | 58k | 3.55 |
| 2024-12-31 | $219k | 58k | 3.80 |
| 2024-09-30 | $181k | 56k | 3.26 |
| 2024-06-30 | $106k | 56k | 1.91 |
| 2024-03-31 | $2.8M | 971k | 2.84 |
| 2023-12-31 | $13M | 895k | 14.72 |
| 2023-09-30 | $444k | 24k | 18.33 |
| 2023-06-30 | $499k | 23k | 21.61 |
| 2023-03-31 | $661k | 23k | 29.37 |
| 2022-12-31 | $579k | 16k | 36.92 |